Arianna Gentilini (@agentilini_) header
Arianna Gentilini (@agentilini_) profile picture

Postdoctoral Researcher @ImperialBiz | PhD @LSEHealthPolicy

London
Joined June 2022
Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)Photo by Arianna Gentilini (@agentilini_)
𝐖𝐡𝐲 𝐂𝐨𝐫𝐫𝐮𝐩𝐭𝐢𝐨𝐧 𝐏𝐞𝐫𝐬𝐢𝐬𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐞𝐜𝐭𝐨𝐫 💰 Corruption drains budgets, erodes trust & fuels inequality in Europe’s health systems. Why does it persist? 👉 Read Iva Parvanova’s blog here: bit.ly/43YOScF
4
9
540
🚨 Job Alert 🚨 4-year postdoc position to work on my ERC project HARSH - Uncovering the Roots of Harsh Parenting. 📍 Dep. of Economics @DSE_Unibo, Bologna, Italy 🇮🇹 📅 Deadline: March 14, 2025 💡 Learn more and apply here: econjobmarket.org/positions/… #econtwitter #econjobmarket #ejm
40
1
96
12,251
Arianna Gentilini retweeted
✨Chuffed to have won the best presentation at @UUUIPS Winter Meeting. Was a great time hearing about different projects at all different cross-sections and meet the policy faculty. @LSEHealthPolicy
2
3
11
518
6/ 📌 While NICE considers many patient-relevant issues, there's room for improvement to ensure all concerns are considered. Increasing diversity of viewpoints and clarifying the management of conflicts of interest can further strengthen the process.
1
1
71
New paper by @IvaParvanova01 & @mylene_lagarde examines how survey wording affects bribery rates in #healthcare.💰Loaded (corruption-linked) vs neutral (payments/gifts) wording reveals notable differences across countries.🔗bit.ly/3Zth1Gt #InternationalAntiCorruptionDay
1
7
332
🚨New Research by @IvaParvanova01 & @agentilini_ on the EU's 24 COI regulation in JCA. 🌟 📊 Key findings: ✔️Progress in transparency for EU-wide HTAs. ✔️Concerns on expert diversity & COI enforcement. ✔️Recs for stronger accountability. 🔗Read now👇bmjopen.bmj.com/content/14/1…
2
5
353
New article w/ @IvaParvanova01 out in @BMJ_Open! 👇🏻
Congratulations to Dr Arianna Gentilini [@agentilini_] whose paper 'Managing experts’ conflicts of interest in the EU Joint Clinical Assessment' has been published in @BMJ_Open 👏 👏 👏 Read the paper: imprl.biz/3ASHyoy #IBResearch
6
117
Arianna Gentilini retweeted
🚨@agentilini_ and I analyze the new COI regulation for EU HTA (#JCA) @BMJ_Open, key points: ✍️No guidance for disclosing the size of financial interests ⚖️No COI mitigation for experts from conflicted orgs or conflicted experts (esp for rare diseases) 👉tinyurl.com/j5y6zkau
1
3
7
458
UK patient organisations took €20m from drug companies in 2022, followed by groups in Belgium, France, Italy and Germany. In a first Europe-wide study, our investigation reveals 11,000+ payments made by pharma industry to advocacy groups and charities: investigate-europe.eu/posts/…
7
1
5
2,152
Access to medicines is a critical indicator of progress towards the SDGs and should not be dropped. Read our recommendations how to strengthen investment in measurement #IAEG Inter-Agency —Expert Group on #SDGs Indicators (IAEG-SDGs) @kjmeetswrld @UNStats ncbi.nlm.nih.gov/pmc/article…
6
1
15
1,911
New publication @TheLancet Oncology by @kjmeetswrld & @agentilini_ examines the clinical benefit, #HTA review times & drug #prices reviewed through #ProjectOrbis, an initiative to streamline regulatory review across international regulators.🔗Read now: bit.ly/45ZFJ48
4
1
7
1,370